Century Therapeutics (IPSC) Other Non-Current Liabilities (2024 - 2026)

Century Therapeutics (IPSC) has 3 years of Other Non-Current Liabilities data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 77.19% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 77.19% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 57.0% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $1.9 million, down from $3.8 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for IPSC reached as high as $9.3 million in Q2 2024 and fell as low as $20000.0 in Q1 2024.
• Historically, Other Non-Current Liabilities has averaged $6.6 million across 3 years, with a median of $8.7 million in 2024.
• Across the five-year window, Other Non-Current Liabilities soared 42400.0% in 2025 and slumped 77.19% in 2026, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $8.7 million in 2024, then slumped by 57.0% to $3.8 million in 2025, then slumped by 48.39% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $9.1 million in Q3 2025.